-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Arcus Biosciences, Inc. quarterly/annual Revenues history and growth rate from Q3 2017 to Q3 2025.
- Arcus Biosciences, Inc. Revenues for the quarter ending September 30, 2025 was $26M, a 45.8% decline year-over-year.
- Arcus Biosciences, Inc. Revenues for the twelve months ending September 30, 2025 was $240M.
- Arcus Biosciences, Inc. annual Revenues for 2024 was $258M, a 121% increase from 2023.
- Arcus Biosciences, Inc. annual Revenues for 2023 was $117M, a 4.46% increase from 2022.
- Arcus Biosciences, Inc. annual Revenues for 2022 was $112M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)